Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Astellas has declined to exercise its option on AviadoBio’s AAV-based gene therapy program targeting frontotemporal dementia (FTD), but the program will continue through nonprofit funding support. The development highlights an alternative pathway for sustaining…
